Aspirin suppresses components of lymphangiogenesis and lymphatic vessel remodeling by inhibiting the NF-κB/VCAM-1 pathway in human lymphatic endothelial cells. Prangsaengtong O*, Jantaree P, Lirdprapamongkol K, Ngiwsara L, Svasti J, Koizumi K. Vasc Med. 2018 Jun;23(3):201-211.

01 Jun 2018
0

Aspirin suppresses components of lymphangiogenesis and lymphatic vessel remodeling by inhibiting the NF-κB/VCAM-1 pathway in human lymphatic endothelial cells.

Prangsaengtong O*, Jantaree P, Lirdprapamongkol K, Ngiwsara L, Svasti J, Koizumi K.

Vasc Med. 2018 Jun;23(3):201-211.

Tags

Share this

Related Posts

Secretomic profiling of cells from hollow fiber bioreactor reveals PSMA3 as a potential cholangiocarcinoma biomarker. Verathamjamras C, Weeraphan C, Chokchaichamnankit D, Watcharatanyatip K, Subhasitanont P, Diskul-Na-Ayudthaya P, Mingkwan K, Luevisadpaibul V, Chutipongtanate S, Champattanachai V, Svasti J, Srisomsap C*. Int J Oncol 2017;51(1):269-80.

Recent Posts